The DTS showed good reliability and validity, and offers promised as a scale which is particularly suited to assessing symptom severity, treatment outcome and in screening for the likely diagnosis of PTSD.

The development of PTSD symptoms after traumatic injury is associated with a more fragmented pattern of REM sleep.

Use of selective serotonin reuptake inhibitors in depressed patients who experience an acute MI might reduce subsequent cardiovascular morbidity and mortality. A controlled trial is needed to examine this important issue.

Background-Prazosin, a CNS active alpha-1 adrenoreceptor antagonist, has reduced nightmares and sleep disturbance in placebo controlled studies of combat-related PTSD. We evaluated objective sleep parameters and PTSD symptoms in a placebo-controlled prazosin trial for civilian traumarelated PTSD.